Cyril V Privezentzev

Title: Cyril V Privezentzev: Innovator in Biopharmaceuticals

Introduction

Cyril V Privezentzev is a notable inventor based in Sawston, GB. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative treatments for various diseases. With a total of 2 patents to his name, Privezentzev's work is at the forefront of medical research.

Latest Patents

One of his latest patents is focused on Shark VNARs for treating COVID-19. This patent provides coronavirus S1-fragment specific binding moieties comprising Type II VNAR domains and VNAR antibodies. The methods described in this patent are aimed at treating COVID-19 effectively. In some embodiments, a VNAR antibody, originally selected from a phage display library as a VNAR clone using S1 fragments from the SARS-CoV-2 Wuhan strain, is also effective at specifically binding to and/or neutralizing SARS-CoV-2 and certain SARS-CoV-2 mutants. Another significant patent involves CTLA-4 variants, which are designed to have high affinity, potency, and stability. These formulations are intended for subcutaneous or intravenous administration, potentially at monthly or less frequent dosage intervals. The use of CTLA-4 variants is aimed at treating rheumatoid arthritis and other inflammatory disorders, with some variants fused with IgG Fc to improve stability and extend in vivo half-life.

Career Highlights

Throughout his career, Cyril V Privezentzev has worked with prominent companies in the biopharmaceutical sector, including Medimmune Limited and Ossianix, Inc. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Privezentzev has collaborated with notable professionals in his field, including Ralph Raymond Minter and Julie Ann Douthwaite. These collaborations have likely enhanced his research and development efforts.

Conclusion

Cyril V Privezentzev is a distinguished inventor whose work in biopharmaceuticals has the potential to impact the treatment of various diseases significantly. His innovative patents and collaborations reflect his commitment to advancing medical science.